Concepedia

Chad Stroud

CS

Statistics

Publications

8

Citations

244

H-Index

8

Active since

1957

Affiliations

Eli Lilly (United States)(Current)

University College London

Chad Stroud is an author at Eli Lilly (United States) specializing in pharmacology, pharmacotherapy, and clinical pharmacology.

ORCID

Publications per year

1957–2022

8

Publications

8

A Randomized, Placebo-Controlled Study of Duloxetine for the Treatment of Children and Adolescents With Generalized Anxiety Disorder

Jeffrey R. Strawn, Apurva Prakash, Qi Zhang et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 2015 · 111 citations

, , +14

Galcanezumab in Patients with Multiple Previous Migraine Preventive Medication Category Failures: Results from the Open-Label Period of the CONQUER Trial

Uwe Reuter, Christian Lucas, David Doležil et al. · Advances in Therapy · 2021 · 37 citations · Full text

, , +15

Tolerability and safety of galcanezumab in patients with chronic cluster headache with up to 15 months of galcanezumab treatment

Miguel J. A. Láinez, Jean Schoenen, Chad Stroud et al. · Headache The Journal of Head and Face Pain · 2021 · 28 citations · Full text

, , +9

Long-term open-label safety study of galcanezumab in patients with episodic or chronic cluster headache

Robert Riesenberg, Charly Gaul, Chad Stroud et al. · Cephalalgia · 2022 · 17 citations

, , +9

Fingerprint Sweat Test in Fibrocystic Disease of Pancreas

J. C. W. MacFarlane, Arne Norman, Chad Stroud · BMJ · 1957 · 14 citations · Full text

, , +13

1–5 of 8